Tech Company Financing Transactions
Magen BioSciences Funding Round
On 8/28/2006, Magen BioSciences received $15.4 million in Series A investment from Highland Capital Partners, Arch Venture Partners and Flybridge Capital Partners.
Transaction Overview
Company Name
Announced On
8/28/2006
Transaction Type
Venture Equity
Amount
$15,400,000
Round
Series A
Investors
Highland Capital Partners (Lead Investor) (Robert Higgins)
Proceeds Purpose
Proceeds from this financing will be used to further develop and expand Magen's therapeutic programs and operations.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Beaver Street 101
Waltham, MA 02453
USA
Waltham, MA 02453
USA
Phone
Website
Email Address
Overview
Magen BioSciences is a specialty pharmaceutical company currently focused on developing proprietary medical therapies for the dermatology market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Gallagher
VP - Bus. Development
Cyrus Mozayeni
VP - R & D
Gordon Letts
Browse more venture capital transactions:
Prev: 8/28/2006: PlayPhone venture capital transaction
Next: 8/28/2006: Trapeze Networks venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs